Jefferies reiterates Buy on ExxonMobil stock, $184 target

Jefferies reiterated a Buy on ExxonMobil, targeting $184, citing strong downstream margins that imply Q2 2026 adjusted net income of ~$13.0B–$16.2B (midpoint ~$14.6B) and EPS of ~$3.53 (slightly below prior/consensus). However, Mizuho cut its price target to $170 (Neutral) on commodity weakness, and Exxon shares fell 2.7% with crude oil declines. The company also plans to redomicile from New Jersey to Texas effective July 1, 2026, alongside a corporate name change—while maintaining the NYSE:XOM ticker and its 3% dividend yield with 43 consecutive years of dividend increases.

Analysis

The market is still pricing XOM like a crude beta name, but the more interesting lever is margin mix: when upstream weakens, downstream and chemicals can cushion earnings and preserve buyback capacity. That makes integrateds relatively defensive versus pure E&P names if oil stays range-bound or drifts lower on de-escalation talks; the bigger loser is the high-beta upstream basket, not XOM.

The next catalyst is earnings, where the question is less about the quarter and more about whether management signals that refining and chemicals are still running above mid-cycle. If that support holds, the estimate path for 2H can move up even without higher oil prices; if it fades, the stock could de-rate quickly because the current multiple already assumes durable cash generation.

Contrarian view: consensus is over-fixated on geopolitics and underweight the risk of mean reversion in downstream margins. A smoother Middle East backdrop can actually be negative for XOM relative to the group because it removes the crude risk premium while leaving the stock exposed to compression in the very segment propping up earnings. TGT has no meaningful read-through here; lower fuel is too indirect and too slow to matter for the tape.

Key Decisions for Investors

• Long XOM vs. short XOP for 1-3 months: own the integrated margin cushion and dividend support while hedging crude beta; cut the short if Brent re-accelerates sharply or if XOM’s earnings call shows downstream normalization.
• Buy XOM on any post-earnings pullback rather than ahead of the print; target a 5-8% total return over 3-6 months if downstream commentary stays constructive and buybacks remain on pace.
• If you want event convexity, use a modest XOM call spread into the July catalyst rather than stock: upside comes from a favorable downstream read-through, while downside is capped if the quarter is merely in-line.
• No trade in TGT; this is not a consumer-demand or margin input story, so forcing a sympathy position would be low edge.